Biophage Pharma Overview

  • Founded
  • 1995

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Biophage Pharma General Information


Developer of phage-based biotechnology product. The company is focused on the development of phage-based technologies for the detection and management of pathogenic bacteria. It operates two divisions: a therapeutic division involved in the management of bacterial contaminations in the medical, veterinary and environmental; and a biosensors division dedicated to the development and commercialization of novel biosensors.

Contact Information

Formerly Known As
Almont Capital
Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Phagelux Canada
Primary Office
  • 6100 Royalmount
  • Montreal, Quebec H4P 2R2
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biophage Pharma Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biophage Pharma‘s full profile, request access.

Request a free trial

Biophage Pharma Executive Team (4)

Name Title Board Seat Contact Info
Theodore Rousseau Chief Executive Officer
You’re viewing 1 of 4 executive team members. Get the full list »